Suppr超能文献

高血压利尿治疗期间的保钾药物。

Potassium-sparing agents during diuretic therapy in hypertension.

作者信息

McKenna T J, Donohoe J F, Brien T G, Healy J J, Canning B S, Muldowney F P

出版信息

Br Med J. 1971 Jun 26;2(5764):739-41. doi: 10.1136/bmj.2.5764.739.

Abstract

Three pharmacological agents in use as "potassium-sparing" drugs have been tested by serial measurements of total exchangeable potassium (K(E)) during 4 to 12 weeks of oral diuretic therapy in hypertensive subjects. Triamterene seemed ineffective in the dosage used (50 mg twice daily). Spironolactone (25 mg twice daily) reduced K loss to a considerable extent, while Slow-K (32 mEq daily) completely reversed previous K(E) deficits. Plasma K levels were a poor indication of degree of K(E) restoration.

摘要

在高血压患者口服利尿剂治疗4至12周期间,通过连续测量总可交换钾(K(E)),对三种用作“保钾”药物的药理剂进行了测试。氨苯蝶啶在所使用的剂量(每日两次,每次50毫克)下似乎无效。螺内酯(每日两次,每次25毫克)在很大程度上减少了钾的流失,而缓释钾(每日32毫当量)则完全逆转了先前的K(E)缺乏。血浆钾水平并不能很好地指示K(E)恢复的程度。

相似文献

引用本文的文献

4
Use of amiloride as a potassium conserving agent in severe cardiac disease.
Br Heart J. 1973 Apr;35(4):456-61. doi: 10.1136/hrt.35.4.456.
7
Diuretics: mechanism of action and clinical application.利尿剂:作用机制与临床应用
Drugs. 1975;9(3):178-226. doi: 10.2165/00003495-197509030-00003.
8
Total exchangeable potassium in response to amiloride.对氨氯吡咪的总可交换钾
Postgrad Med J. 1978 Aug;54(634):533-7. doi: 10.1136/pgmj.54.634.533.

本文引用的文献

2
ULCERATIVE-OBSTRUCTIVE LESIONS OF THE SMALL INTESTINE.小肠溃疡性梗阻性病变
JAMA. 1965 Feb 22;191:641-4. doi: 10.1001/jama.1965.03080080031007.
5
FURTHER OBSERVATIONS CONCERNING THE HYPERGLYCEMIC ACTIVITY OF BENZOTHIADIAZINES.
Diabetes. 1964 Mar-Apr;13:115-21. doi: 10.2337/diab.13.2.115.
6
BODY COMPOSITION IN HYPOKALEMIC FAMILIAL PERIODIC PARALYSIS.低钾性家族性周期性麻痹的身体成分
Ann N Y Acad Sci. 1963 Sep 26;110:993-1008. doi: 10.1111/j.1749-6632.1963.tb15816.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验